Published in Zentralbl Bakteriol on October 01, 1991
Klebsiella pneumoniae: Going on the Offense with a Strong Defense. Microbiol Mol Biol Rev (2016) 0.98
Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis (1982) 5.40
Microbial colonization of prosthetic devices. II. Scanning electron microscopy of naturally infected intravenous catheters. Zentralbl Bakteriol Mikrobiol Hyg B (1981) 3.53
Pigment formation for differentiating Cryptococcus neoformans from Candida albicans. Appl Microbiol (1971) 2.41
Antimicrobial susceptibility of Acinetobacter species. Antimicrob Agents Chemother (1993) 2.23
Pseudocoagulase activity of staphylococci. J Clin Microbiol (1979) 2.10
[Cryptococcus neoformans: pigment formation on polyphenols]. Med Microbiol Immunol (1971) 1.98
Microbial colonization of prosthetic devices. III. Adhesion of staphylococci to lumina of intravenous catheters perfused with bacterial suspensions. Zentralbl Bakteriol Mikrobiol Hyg B (1981) 1.97
Pathogenesis and management of Staphylococcus epidermidis 'plastic' foreign body infections. J Antimicrob Chemother (1984) 1.96
Role of Staphylococcus protease in the development of influenza pneumonia. Nature (1987) 1.96
Microbial colonization of prosthetic devices. I. Microtopographical characteristics of intravenous catheters as detected by scanning electron microscopy. Zentralbl Bakteriol Mikrobiol Hyg B (1981) 1.95
Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality. Medicine (Baltimore) (1995) 1.88
Fermentative and serological studies on Propionibacterium acnes. Appl Microbiol (1973) 1.71
Detection of 4-quinolone resistance mutation in gyrA gene of Shigella dysenteriae type 1 by PCR. Antimicrob Agents Chemother (1994) 1.66
The distribution of Acinetobacter species in clinical culture materials. Zentralbl Bakteriol (1993) 1.65
Investigations on staphylococcal infection of transvenous endocardial pacemaker electrodes. Am Heart J (1984) 1.63
[Coagulase-negative staphylococci (Staphylococcus albus) as pathogens]. Dtsch Med Wochenschr (1967) 1.61
Comparative analysis of a biofilm-forming Staphylococcus epidermidis strain and its adhesion-positive, accumulation-negative mutant M7. FEMS Microbiol Lett (1994) 1.60
In-vitro efficacy of a central venous catheter ('Hydrocath') loaded with teicoplanin to prevent bacterial colonization. J Hosp Infect (1992) 1.55
Implant infections: a haven for opportunistic bacteria. J Hosp Infect (2001) 1.49
Comparison of four different methods for epidemiologic typing of Acinetobacter baumannii. J Clin Microbiol (1994) 1.49
Investigation on extracellular slime substance produced by Staphylococcus epidermidis. Zentralbl Bakteriol Mikrobiol Hyg A (1984) 1.49
Attachment of staphylococci to various synthetic polymers. Zentralbl Bakteriol Mikrobiol Hyg A (1984) 1.48
Efficacy of silver-coated medical devices. J Hosp Infect (1998) 1.48
Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine. J Immunol (1986) 1.47
Plasmid DNA fingerprinting of Acinetobacter species other than Acinetobacter baumannii. J Clin Microbiol (1994) 1.46
Antibacterial activity of temocillin (BRL 17421), a new semisynthetic penicillin. J Antimicrob Chemother (1982) 1.46
Structure of the L5 lipopolysaccharide core oligosaccharides of Neisseria meningitidis. J Biol Chem (1990) 1.45
Antimicrobiol susceptibility of Propinibacterium acnes and related microbial species. Antimicrob Agents Chemother (1976) 1.44
Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity. Virology (1987) 1.40
[Clinical and preclinical efficacy of antimicrobial catheters]. Anasthesiol Intensivmed Notfallmed Schmerzther (1997) 1.40
Vascular catheter-related bloodstream infection due to Acinetobacter johnsonii (formerly Acinetobacter calcoaceticus var. lwoffi): report of 13 cases. Clin Infect Dis (1993) 1.36
Plasmid DNA profiles of Acinetobacter baumannii: clinical application in a complex endemic setting. Infect Control Hosp Epidemiol (1994) 1.35
Studies on bacteriophages of Propionibacterium acnes. Med Microbiol Immunol (1975) 1.33
Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial. Anticancer Res (2004) 1.33
Actinobacillus actinomycetem-comitans: fermentative capabilities of 140 strains. Appl Microbiol (1970) 1.31
New bacteriophages of Staphylococcus epidermidis. J Infect Dis (1975) 1.30
The epitope associated with the binding of the capsular polysaccharide of the group B meningococcus and of Escherichia coli K1 to a human monoclonal macroglobulin, IgMNOV. J Exp Med (1988) 1.27
Bacteremia due to Acinetobacter species other than Acinetobacter baumannii. Infection (1995) 1.24
Comparative in vitro activity of cefotaxime (HR 756). Chemotherapy (1980) 1.22
N-propionylated group B meningococcal polysaccharide mimics a unique epitope on group B Neisseria meningitidis. J Exp Med (1987) 1.21
Antibiotics and immunomodulation: effects of cefotaxime, amikacin, mezlocillin, piperacillin and clindamycin. Med Microbiol Immunol (1985) 1.19
The core structure of Shigella sonnei lipopolysaccharide and the linkage between O-specific polysaccharide and the core region. Eur J Biochem (1982) 1.15
[Deposition of 2,3-dihydroxybenzoic acid and its amino acid derivatives by Klebsiellas and Escherichia coli]. Med Microbiol Immunol (1971) 1.15
[Prevention, diagnosis, therapy, and follow-up of lung cancer]. Pneumologie (2010) 1.14
Evaluation of the lysostaphin-susceptibility test for the classification of staphylococci. J Med Microbiol (1979) 1.09
[Occurrence of NAG vibrios (non-cholera vibrios) in West Germany]. Dtsch Med Wochenschr (1973) 1.09
The nature of clotting and fibrinolytic activities of Bacteroids melaninogenicus. Zentralbl Bakteriol Orig A (1978) 1.06
Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society. Pneumologie (2010) 1.06
Susceptibility of Bacteroides melaninogenicus to 45 antibiotics. Chemotherapy (1980) 1.03
Prothrombin activation by a metalloprotease from Staphylococcus aureus. J Clin Microbiol (1980) 1.03
Deoxyribonucleic acid reassociation in the classification of the 'rhodochrous' complex and allied taxa. J Gen Microbiol (1976) 1.02
[Antibody response to group A streptococcal exoenzymes (author's transl)]. Dtsch Med Wochenschr (1976) 1.02
Structure and immunochemistry of meningococcal lipopolysaccharides. Antonie Van Leeuwenhoek (1987) 1.01
[Bacteriophages of Propionibacterium acnes (author's transl)]. Zentralbl Bakteriol Orig A (1973) 1.01
Antibiotic resistance of Staphylococcus albus. Med Microbiol Immunol (1972) 1.01
Controlled release of antibiotics from biomedical polyurethanes: morphological and structural features. Biomaterials (1997) 1.01
Serological studies on Actinobacillus actinomycetem-comitans. Appl Microbiol (1972) 1.00
In-vitro activity of ticarcillin with and without clavulanic acid against clinical isolates of gram-positive and gram-negative bacteria. J Antimicrob Chemother (1986) 0.99
Cloning, sequencing, and expression of the mig gene of Mycobacterium avium, which codes for a secreted macrophage-induced protein. Infect Immun (1997) 0.99
A four-year prospective study on microbial ecology of explanted prosthetic hips in 52 patients with "aseptic" prosthetic joint loosening. Eur J Clin Microbiol Infect Dis (1996) 0.98
Antimicrobial substances and effects on sessile bacteria. Zentralbl Bakteriol (1999) 0.97
Staphylococcus pulvereri sp. nov., isolated from human and animal specimens. Int J Syst Bacteriol (1995) 0.97
Differential susceptibility of Propionibacterium acnes, P. granulosum and P. avidum to free fatty acids. J Invest Dermatol (1978) 0.97
The biochemical properties and antibiotic susceptibility of Bacteroides melaninogenicus. Med Microbiol Immunol (1971) 0.96
Hemagglutinins of Klebsiella pneumoniae and Klebsiella oxytoca. Zentralbl Bakteriol Mikrobiol Hyg A (1983) 0.96
Prevalence of serum antibodies to toxic-shock-syndrome-toxin-1 and to staphylococcal enterotoxins A, B and C in West-Germany. Zentralbl Bakteriol Mikrobiol Hyg A (1988) 0.96
Unique intermolecular bactericidal epitope involving the homosialopolysaccharide capsule on the cell surface of group B Neisseria meningitidis and Escherichia coli K1. J Immunol (1989) 0.95
Susceptibility of Bacterium actinomycetem comitans to 45 antibiotics. Antimicrob Agents Chemother (1980) 0.94
Effect of sepsis and cardiac surgery with cardiopulmonary bypass on plasma level of nitric oxide metabolites, neopterin, and procalcitonin: correlation with mortality and postoperative complications. Intensive Care Med (2000) 0.94
Campylobacter and Salmonella contaminating fresh chicken meat. Zentralbl Bakteriol (1996) 0.94
Methicillin-resistant Staphylococcus haemolyticus on the hands of health care workers: a route of transmission or a source? J Hosp Infect (1995) 0.93
In vitro-activity of clavulanic acid and amoxicillin combined against amoxicillin-resistant bacteria. Infection (1980) 0.93
Susceptibility of Staphylococcus aureus and group A, B, C, and G streptococci to free fatty acids. J Clin Microbiol (1979) 0.93
Influence of postoperative complementary treatment with lectin-standardized mistletoe extract on breast cancer patients. A controlled epidemiological multicentric retrolective cohort study. Anticancer Res (2004) 0.93
[Animal experiment studies on the modification of the immune system by ofloxacin]. Infection (1986) 0.93
In-vitro efficacy of a central venous catheter complexed with iodine to prevent bacterial colonization. J Antimicrob Chemother (1992) 0.92
Immunostimulation by propionibacteria--effects on immune status and antineoplastic treatment. Anticancer Res (1996) 0.92
Use of a phage set for the ecological typing of coagulase-negative staphylococci. Zentralbl Bakteriol Orig A (1978) 0.92
Differentiation of coagulase-negative staphylococci by bacteriophage-typing. Contrib Microbiol Immunol (1973) 0.91
Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MTH-68/H). Anticancer Res (1999) 0.91
[Prevention, diagnosis, therapy, and follow-up of lung cancer. Interdisciplinary guideline of the German Respiratory Society and the German Cancer Society--abridged version]. Pneumologie (2011) 0.91
Stimulation of human monocyte chemiluminescence by staphylococcal lipoteichoic acid. Med Microbiol Immunol (1988) 0.90
The phage adsorption test: a simple method for differentiation between staphylococci and micrococci. J Infect Dis (1978) 0.90
[Isolation of an antibacterial active tropolone from a Pseudomonas cepacia strain]. Zentralbl Bakteriol Mikrobiol Hyg A (1982) 0.90
Typing of coagulase-negative staphylococci isolated from foreign body infections. Eur J Clin Microbiol Infect Dis (1988) 0.90
Problems of human actinomycosis. Postepy Hig Med Dosw (1974) 0.90